| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-07 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |